Can asthma severity be a predictor of exacerbation severity? Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Immunoproteasome function as a potential biomarker for asthma severity and response to therapy Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021
Cough rate may predict disease severity in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 536s Year: 2004
A new paradigm for classification of disease severity and progression of COPD Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012
Umeclidinium/vilanterol in preventing clinically important deterioration (CID) in COPD and impact of baseline disease severity: the EMAX trial Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020
Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004
Is there any relationship between the duration to diagnosis of COPD and severity of the disease? Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012
Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score. Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Which is the most effective inflammatory marker in the diagnosis, severity and treatment follow-up of patients with pneumonia? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
An audio-imaging approach to measure the degree of severity of patients suffering from DPLD disease Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018
Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …? Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets? Year: 2019
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Development of a predictive model for chronic obstructive pulmonary disease onset with identification and ranking of risk factors Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Do baseline measurements predict response to treatment in patients with idiopathic hyperventilation? Source: Eur Respir J 2006; 28: Suppl. 50, 864s Year: 2006
Can changes in questionnaire scores be used as a surrogate for physiological response to treatment in patients with idiopathic hyperventilation? Source: Eur Respir J 2006; 28: Suppl. 50, 571s Year: 2006
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016